Showing posts with label mice. Show all posts
Showing posts with label mice. Show all posts

Tuesday, December 20, 2022

Mice With a Healthy Gut Microbiome Are More Motivated to Exercise

reposted from https://www.the-scientist.com/news-opinion/mice-with-a-healthy-gut-microbiome-are-more-motivated-to-exercise-70845?utm_campaign=TS_DAILY_NEWSLETTER_2022&utm_medium=email&_hsmi=238698979&_hsenc=p2ANqtz-_ymMGFDXk8FwZj9ol6Ge0rVxC-_oiDn4m4ofgcFD6cZlpoxtOelPBFQEdpq6BDv4MMh_wFge2mwPYQOnZ3Dz61bMwgUQ&utm_content=238698979&utm_source=hs_email Mice With a Healthy Gut Microbiome Are More Motivated to Exercise A neural pathway between the gut and the brain led to the release of dopamine when the mice ran on a wheel or treadmill, but only in the presence of a robust microbiome. a white mouse sits on a blue exercise wheel, looking out onto the shavings below A black and white headshot of Katherine Irving Katherine Irving Dec 16, 2022 | 4 min read PDF VERSION ABOVE: © ISTOCK.COM, MARY SWIFT The gut is a jungle teeming with microorganisms that are instrumental to the process of digesting food, regulating metabolism, and defending against infection. However, research now suggests yet another way that the gut microbiome’s influence extends far past the bounds of its abdominal home. In mice, gut bacteria stimulate the production of dopamine during exercise, without which the mice lack the motivation to continue running, scientists at the University of Pennsylvania reported December 14 in Nature. “This is the most comprehensive study I have ever seen,” says Theodore Garland Jr., an evolutionary physiologist studying the gut-brain axis in mice at the University of California, Riverside, who wasn’t involved in the research. “[It’s] pulling together lots of different pieces that we knew before in different contexts or in isolation of other parts in a way that hasn’t been done before.” Exercise is “the single most effective lifestyle intervention that we have that protects us from a very large range of diseases,” says study coauthor Christoph Thaiss, a microbiologist at the University of Pennsylvania Perelman School of Medicine. Yet despite being a very physical activity, he says the success of an individual’s attempts to exercise often depends on their mental state. “If you look at what elite athletes say, many of them will say that they are not necessarily physically better than their competitors, but their mind is very well prepared,” he says. “But when it comes to preparing athletes, mentally or motivationally, for their competitions, there’s very little scientific evidence of how these methods might work.” Previous research had already found that the gut microbiome can influence muscle tissue and cardiovascular fitness as well as brain chemistry. But Thaiss aimed to bring such findings together and examine the broader role of the gut microbiome in exercise performance. So, he and his colleagues set up an experiment using 199 outcrossed mice from eight different genetic backgrounds to ensure that any findings weren’t limited to one strain. Using multiple antibiotics, the researchers altered the mice’s microbiome communities: some mice had fully functioning microbiomes, while the others had their gut microbiomes either partially or entirely removed. See “Tinkering with Gut Microbes Boosts Brain Plasticity in Mice” They then tested each mouse’s performance while running in two different settings: a treadmill, on which the mice were forced to run for an extended period to test their endurance, and a wheel, on which the mice were allowed to run as often and for as long as they wanted. Although all the mice were equally capable of moving around their cages, the mice with reduced microbiomes tired more quickly when exercising on the treadmill than mice with robust microbiomes. They also spent less time on the wheel, which the researchers attributed to reduced motivation to exercise. Thaiss then searched for a neural explanation for the behavioral differences among the groups of mice. He and his team used RNA sequencing to analyze the mice’s striatal spiny neurons, which are involved in producing the behavior-reinforcing neurotransmitter dopamine both before and after exercise, and found that many of the genes normally expressed during exercise were dampened without the microbiome. When he performed an experiment limiting dopamine production during exercise by inhibiting these neurons, it had the same effect that limiting or entirely removing the microbiome had in the previous experiment. From these experiments, Thaiss inferred that the production of dopamine was a significant factor in a mouse’s propensity to exercise, and that a mouse’s gut microbiome composition played some role in the regulation of dopamine in its brain. That led him to conclude that the mice lacking gut bacteria didn’t experience the dopamine rush animals usually get through exercise, known as the “runner’s high.” “If we can remote[ly] control the brain from the perspective of the GI tract, then this becomes a much more accessible problem.” —Christoph Thaiss, University of Pennsylvania Perelman School of Medicine The question then became how microbes in the gut influence dopamine in the brain. To find out, the team inhibited a set of neurons that connects the gastrointestinal tract to the brain using formulated drugs. In the same wheel and treadmill experiments as before, mice with healthy microbiomes but inhibited gut-brain neurons exhibited reduced exercise rates on par with the mice with limited microbiomes, suggesting that it was the stimulation of these neurons that controlled the amount the mice exercised. Finally, the researchers treated mice with specific antibiotics to determine what kinds of microbes were triggering the neurons. They performed a metabolomics analysis to determine which bacterial metabolites triggered the neural response. They found that metabolites known as fatty acid amides (FAAs) made by some microbes found in a healthy mouse gut were the most active during exercise. These FAAs generate neurotransmitters known as endocannabinoids. The scientists performed more experiments using ingestible inhibitors to determine that the endocannabinoids produced by the bacteria’s FAAs were stimulating receptors in the GI tract neurons during exercise, thereby triggering the neurons that subsequently stimulated dopamine production in the brain. “It was really elegant the way they structured the entire story,” says Francesca Ronchi, an immunologist at the Institute of Microbiology, Infectious Diseases and Immunology in Berlin, Germany who wasn’t involved in the study. She adds that she was very impressed by the thoroughness of the paper. “You couldn’t do it better.” Thaiss says that the next step will be to take this research from mice to humans and determine whether the same pathway exists in us. Garland explains that analyzing motivation in humans is more complicated than it is in mice: a person’s incentive to exercise is based on many more factors, including external ones such as their social environment and influence from family or friends, than is a mouse’s. “We don’t go and give our mice pep talks when they run a lot on the wheel,” he observes. In humans, by contrast, those that are naturally talented at some form of exercise may receive more praise, fueling them to exercise more. See “Regular Exercise Helps Patients Combat Cancer” Nonetheless, Ronchi says findings like these could one day reveal ways to stimulate exercise in those who need it, including cancer, Parkinson’s, or Alzheimer’s patients, for whom exercise is a valuable tool in mitigating symptoms. After all, if such a pathway does exist in people, gut microbes may be easier to manipulate or influence than neurons in the brain, Thaiss suggests: Unlike neurons, which are finicky and often inaccessible, gut bacteria could be influenced by an ingestible treatment. “If we can remote[ly] control the brain from the perspective of the GI tract, then this becomes a much more accessible problem,” he says. “But that’s still science fiction for now.” Keywords: bacteriaexercisefitnessgut bacteriagut microbiotaimmunologymicrobiologymicrobiomemicrobiotamouse studyneural activationneuronneurotransmittersNewspathwaysignaling pathwaysstudy story

Tuesday, February 27, 2018

Editorial: Intrinsic Clocks

reposted from https://www.frontiersin.org/articles/10.3389/fneur.2018.00068/full  and it suggests how important circadian rhythms are for life.....


EDITORIAL ARTICLE

Front. Neurol., 16 February 2018 | https://doi.org/10.3389/fneur.2018.00068

Editorial: Intrinsic Clocks

  • 1Department of Public Health Solutions, National Institute for Health and Welfare (THL), Helsinki, Finland
  • 2Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Vienna, Austria
Editorial on the Research Topic
The existence of living organisms on our planet has been dependent on and co-evolved with the foreseeable variations in environmental conditions oscillating over recurring periods. All species have responded to these exogenous rhythms by developing endogenous clocks that allow for an approximate, but reliable estimation of the periodic changes and elicit corresponding adaptive processes.
The importance of these mechanisms for health and disease has been highlighted by the 2017 award of the Nobel Prize in Physiology or Medicine to Jeffrey C. Hall, Michael Rosbash, and Michael W. Young for their discoveries of the genetic control of the daily biological rhythm. They explained in molecular terms how the gene named as period contributed to the emergence (eclosion from the pupal case) rhythm of a population and to the locomotor activity of individual flies (Drosophila melanogaster). The key to the explanation was the discovery of transcription-translation feedback loops of the so-called “clock genes.”
This research topic on Intrinsic Clocks which appeared earlier comprises a well-balanced collection of original research and review articles on endogenous rhythms from seasonal and monthly to daily and hourly oscillations in different experimental model systems with analytical approaches from systemic to cellular and molecular levels.
Serchov and Heumann in their review focus on the role of Ras, an enzyme which hydrolyzes guanosine triphosphate and dependent intracellular signaling cascades in the regulation of the circadian rhythm in mice. They elegantly summarize how Ras activity forms a molecular bridge between entrainment of the suprachiasmatic nucleus that is the master clock in the brain and synaptic plasticity in dependent brain regions, such as the hippocampus, and corresponding functions. The extensive study by Chiang et al. specifically investigated rhythmic alterations in the murine hippocampus. They characterized the protein phosphorylation using a mass spectrometry approach with which they provided large-scale quantitative analysis of the daily oscillation of hippocampal phosphorylation events over a range of biological pathways. The hippocampus is a key focus also in the review by Urs Albrecht. It features the role of circadian proteins in the control of adult hippocampal neurogenesis, reciprocally implicated in depression and antidepressant responses. He discusses neurobiological mechanisms implicated in the pathogenesis of mood disorders, such as monoaminergic neurotransmission and stress response by the hypothalamic–pituitary–adrenal axis. The hypothalamus and the pituitary are further involved in seasonal cycles as highlighted in the review by Lewis and Ebling who elaborate in detail on the role of tanycytes, pituitary radial glial cells, in the regulation of circannual clocks in hamsters. They provide evidence supporting their hypothesis that tanycytes serve as central organizers of seasonal rhythms in the adult hypothalamus. Raible et al. present in their review on marine animals the current insight in the cellular mechanisms in molecular detail the monthly or semi-monthly rhythms. They express their worry about light pollution and further review the relevance of circalunar rhythms to mammalian physiology and reproduction in specific. They speculate that these rhythms may be the remnant of evolutionary ancient clocks, which were uncoupled from a natural entrainment mechanism.
Bourguignon and Storch summarize recent findings of the cellular substrate and mechanism, which generate locomotor activity with periods of 2–6 h. Such rhythms are normally integrated with circadian rhythms, but often lack the period stability and expression robustness. They further review the concept of the dopaminergic ultradian oscillator and show that ultradian locomotor rhythms rely on cells in the brain using dopamine for transmission. Intriguingly, Monje et al. report in their study on interleukin-6 knockout mice that the ultradian locomotor rhythm was impaired under both light-entrained and free-running conditions, whereas the circadian period and the level of locomotor activity as well as the phase shift response to light exposure at night remained normal. During the day, Cry1 and Bhlhe41 expression levels were increased whereas those of Nr1d2 were decreased in the hippocampus. Liu and Zhang first created mutants of cryptochrome circadian clock 1 (Cry1) protein at potential phosphorylation sites and conducted thereafter a screen in Cry1/Cry2 double deficient cells. They targeted at identifying mutations that disrupted circadian rhythms. They found that these single amino acid substitutions changed not only the circadian period, but also repression activity, protein stability, or cellular localization of the protein. Concerning the circadian period, Narasimamurthy and Virshup elucidate in their review the molecular mechanisms that regulate an enigma of the clock. Unlike other chemical reactions, the output of the clock as measured with the period remains nearly constant with fluctuations in ambient temperature. This is called as temperature compensation. The key lies especially in the mechanism that controls the stability of period circadian clock 2 protein. Clock-enhancing small molecules have become of particular interest as candidate chronotherapeutics, since there is a close association of circadian amplitude dampening with progression of chronic diseases, especially that of mood disorders. Gloston et al. present in their review an update of the regulatory mechanisms of circadian amplitude and the current status of these small molecules of therapeutic interest. Millius and Ueda introduce the readers to study of biology which takes advantage of engineering and mathematical tools to model and test the behaviors of the intrinsic clocks. It has evolved through the development of both wet lab and in silico work. The goal here is to understand the clocks that are made up of a range of complex properties of cells, tissues, and organisms.
The cross-section of studies comprised in this research topic on Intrinsic Clocks highlights the vibrant scientific activity in the field of the investigation of endogenous biological rhythms and their relevance for physiology and pathology.

Author Contributions

TP and DP planned and wrote the manuscript together.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Keywords: circadian rhythm, depression, marine biology, mouse model, plasticity, seasonality, small-molecule, systems biology
Citation: Partonen T and Pollak DD (2018) Editorial: Intrinsic Clocks. Front. Neurol. 9:68. doi: 10.3389/fneur.2018.00068
Received: 04 December 2017; Accepted: 29 January 2018;
Published: 16 February 2018
Edited and Reviewed by: Yves A. Dauvilliers, Hôpital Gui De Chauliac, France
Copyright: © 2018 Partonen and Pollak. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Timo Partonen, timo.partonen@thl.fi

Friday, March 24, 2017

Gene-blocking therapy reverses Alzheimer’s-like symptoms in mice

reposted from
https://www.newscientist.com/article/2119254-gene-blocking-therapy-reverses-alzheimers-like-symptoms-in-mice/

Gene-blocking therapy reverses Alzheimer’s-like symptoms in mice


Image of neurons with tau tangles in green
The treatment appears to destroy tau tangles (green)
Sarah DeVos
Targeting tangles of tau protein in mice with Alzheimer’s-like symptoms has reversed their brain damage, halting memory loss and extending their lives.
Clumps of two types of sticky protein build up in the brains of people with Alzheimer’s disease: beta-amyloid plaques, and tangles of tau. While many attempts to develop drugs to treat Alzheimer’s have targeted beta-amyloid, tau protein tangles have long been suspected to play a role in memory loss.
“Tau is what correlates with memory problems, so one hypothesis is that lowering tau could be beneficial,” says Tim Miller of Washington University in St Louis, Missouri.
Now Miller’s team has purged tau tangles from the brains of Alzheimer’s-like mice for the first time. They used fragments of RNA called antisense oligonucleotides to sabotage the gene that makes tau, preventing it from being fully translated into protein.
Once a day for four weeks, the team injected the antisense treatment, named Tau-ASO12, into the fluid at the base of each mouse’s spine. The mice had been genetically engineered to make a rogue form of tau similar to what is seen in people with Alzheimer’s, predisposing the mice to developing tau-related brain problems.
The drug successfully spread throughout the brain, and was linked to a reduction in levels of tau that was made. It also seemed to destroy existing tau tangles, and prevent tau from spreading around the brain in older mice.

Skills retained

Overall, mice that got Tau-ASO12 lived up to 50 days longer than those that didn’t, and were able to retain important abilities, such as nest-making skills, that were lost in mice that received a sham treatment.
When Miller’s team gave the antisense treatment to cynomolgus monkeys, they saw around a 20 per cent reduction in the amount of tau detected in spinal fluid samples, with no apparent side effects – early evidence that the therapy may hold promise for treating humans.
Before testing the treatment in people, the team will further assess its safety and efficacy in larger primate animals. One concern is that lowering levels of a brain protein like tau could affect normal brain function.
“We don’t know for sure what tau does in the brain,” says Michel Goedert at the Laboratory of Molecular Biology in Cambridge, UK, who showed in 2009 that tau can spread from one brain cell to another. However, mice that are genetically modified not to produce any tau are healthy for most of their lifespan, he says. “We believe that reducing tau levels by something like 30 per cent will not cause any ill effects, but will be beneficial in terms of preventing neurodegeneration.”
Miller says any human Tau-ASO12 treatment would likely be injected into the cerebrospinal fluid at the base of the spine, and would probably have to be given around once a month. Similar antisense treatments have already been given safely to people with amyotrophic lateral sclerosis (motor neurone disease) and Huntington’s disease.
Tau is implicated in several other neurodegenerative conditions, including progressive supranuclear palsy and frontotemporal dementia, and it’s possible that such a treatment could also benefit people with these conditions.
Journal reference: Science Translational MedicineDOI: 10.1126/scitranslmed.aag0481

More on these topics:

Friday, March 13, 2015

Ultrasound shows new promise as Alzheimer’s treatment

reposted from

Scientists believe they may have found a new weapon in the fight against Alzheimer’s disease – not in the form of a drug but in focused beams of ultrasound. (Hayden Bird/iStockphoto)

Ultrasound shows new promise as Alzheimer’s treatment


Scientists believe they may have found a new weapon in the fight against Alzheimer’s disease – not in the form of a drug but in focused beams of ultrasound.
While the approach has been tested only in mice, researchers said on Wednesday it proved surprisingly good at clearing tangles of plaques linked to Alzheimer’s in the animals’ brains and improving their memory, as measured by tests such as navigating a maze.
In the past, high-energy ultrasound has been combined with injected microbubbles, which vibrate in response to sound waves, to get drugs across the so-called blood-brain barrier.
But the new research, published in the journal Science Translational Medicine, is the first demonstration that ultrasound alone might have a beneficial effect in the memory-robbing condition.
“Our research was very exploratory and we really didn’t expect to see such a massive effect,” said Dr. Juergen Goetz of the University of Queensland in Brisbane, one of the study authors. “I’m really excited by this.”
After several weeks of treating mice that had been genetically altered to produce amyloid plaques, the scientists found the ultrasound almost completely cleared the plaques in 75 per cent of the animals, without apparent damage to brain tissue.
While there is still some debate as to whether plaques are a cause or a symptom of Alzheimer’s, the experiment found that the treated mice had improved memory, as measured by three different tests, compared with untreated ones.
The technique works by stimulating microglial cells, which form part of the brain’s immune system, to engulf and absorb the plaques. Goetz stressed that his research, which used an ultrasound machine from Philips, was at a very early stage and it would be several years before it could be tested in people.
Several hurdles must be overcome first, including long-term checks for side effects in animals and much more research into whether the approach will work with thicker skulls and larger brains.
The next step is to treat sheep, with data from that experiment expected later this year.
Ultrasound devices capable of penetrating the human brain are already being tested for other conditions, with Israeli company InSightec pioneering it for tremors and chronic pain.
Dementia, of which Alzheimer’s is the most common form, affects close to 50 million people worldwide and that number is expected to reach 135 million by 2050, according to Alzheimer’s Disease International, a non-profit campaign group.
 

TOPICS: